M Shibata

1.1k total citations
25 papers, 931 citations indexed

About

M Shibata is a scholar working on Epidemiology, Hepatology and Cell Biology. According to data from OpenAlex, M Shibata has authored 25 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Hepatology and 5 papers in Cell Biology. Recurrent topics in M Shibata's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (8 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). M Shibata is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (8 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). M Shibata collaborates with scholars based in Japan, Canada and United Kingdom. M Shibata's co-authors include Yuki Otsuki, Zhuoyu Li, Stefan Adams, K Minami, Hideo Yamane, Yukio Shimane, Yoshihiko Seino, Akitoshi Hayashi, M. Tatsumisago and Kosuke Kuwabara and has published in prestigious journals such as Plastic & Reconstructive Surgery, Solid State Ionics and Applied Clay Science.

In The Last Decade

M Shibata

24 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Shibata Japan 12 417 237 157 104 99 25 931
Wanxia Li China 24 663 1.6× 124 0.5× 332 2.1× 330 3.2× 164 1.7× 55 1.4k
Yasutaka Sasaki Japan 16 238 0.6× 345 1.5× 557 3.5× 14 0.1× 41 0.4× 46 1.4k
Tongyi Huang China 17 107 0.3× 126 0.5× 311 2.0× 19 0.2× 88 0.9× 37 1.2k
Shuhua Zhou China 15 119 0.3× 207 0.9× 246 1.6× 26 0.3× 35 0.4× 31 747
Dayun Yang China 22 80 0.2× 260 1.1× 457 2.9× 25 0.2× 25 0.3× 33 1.3k
Yueying Zhang China 15 396 0.9× 102 0.4× 215 1.4× 101 1.0× 31 0.3× 57 892
Guanwu Li China 19 445 1.1× 115 0.5× 349 2.2× 113 1.1× 181 1.8× 40 1.1k
Sanshiro Hanada Japan 20 106 0.3× 585 2.5× 435 2.8× 29 0.3× 30 0.3× 44 1.5k
Seul Lee South Korea 14 286 0.7× 89 0.4× 322 2.1× 51 0.5× 27 0.3× 41 845
Anna Guller Australia 20 66 0.2× 434 1.8× 238 1.5× 31 0.3× 18 0.2× 50 1.3k

Countries citing papers authored by M Shibata

Since Specialization
Citations

This map shows the geographic impact of M Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Shibata more than expected).

Fields of papers citing papers by M Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Shibata. The network helps show where M Shibata may publish in the future.

Co-authorship network of co-authors of M Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of M Shibata. A scholar is included among the top collaborators of M Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Shibata. M Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shibata, M, Junji Morimoto, Etsuko Shibata, & Y. Otsuki. (2008). Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Therapy. 15(12). 776–786. 50 indexed citations
2.
Kohno, Yoshiumi, Shuji Ikoma, Keiko Yoda, et al.. (2008). Stabilization of natural anthocyanin by intercalation into montmorillonite. Applied Clay Science. 42(3-4). 519–523. 72 indexed citations
3.
Shibata, M, et al.. (2006). Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis. Cancer Gene Therapy. 14(3). 268–278. 9 indexed citations
4.
Shibata, M, et al.. (2005). Long-Term Outcome of Radial Shortening with or Without Ulnar Shortening for Treatment of Kienböck’s Disease: A 13–25 Year Follow-Up. Journal of Hand Surgery (European Volume). 30(2). 226–228. 43 indexed citations
5.
Inoue, Yoshiaki, Masato Homma, Yumi Matsuzaki, et al.. (2005). Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy. Hepatology Research. 34(1). 23–27. 33 indexed citations
6.
Taniguchi, H., et al.. (2004). Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma. Scandinavian Journal of Gastroenterology. 39(12). 1272–1279. 11 indexed citations
7.
Miyachi, Kiyomitsu, Yasuhiro Hirano, Tsuneyo Mimori, et al.. (2004). Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibitin vitronuclear envelope assembly. Clinical & Experimental Immunology. 136(3). 568–573. 22 indexed citations
8.
Otsuki, Yuki, Zhuoyu Li, & M Shibata. (2003). Apoptotic detection methods — from morphology to gene. Progress in Histochemistry and Cytochemistry. 38(3). 275–339. 128 indexed citations
9.
Hashimoto, Tomohiro, et al.. (2003). Elevated levels of intracellular Ca 2+ and apoptosis in human lung cancer cells given heat-shock. International Journal of Hyperthermia. 19(2). 178–192. 3 indexed citations
10.
Horigome, Tsuneyoshi, et al.. (2002). A male patient who developed late-onset primary biliary cirrhosis presenting with antinuclear envelope antibodies. Modern Rheumatology. 12(3). 246–249. 1 indexed citations
11.
Shibata, M. (2001). [Infant case of acute otitis media due to PISP not eradicated with double-dose of CDTR].. PubMed. 54 Suppl B. 99–99. 1 indexed citations
12.
Miyakawa, Hiroshi, Kazuhiro Abe, Hirotoshi Fujikawa, et al.. (1997). [Western blot analysis of anti-M2 antibodies in anti-mitochondrial antibody-negative primary biliary cirrhosis].. PubMed. 45(11). 1079–84. 1 indexed citations
13.
14.
Shibata, M, et al.. (1996). [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].. PubMed. 44(9). 877–82. 2 indexed citations
15.
Shibata, M, et al.. (1995). Autoantibodies against nuclear envelope in patients with primary biliary cirrhosis. International Hepatology Communications. 4(1). 46–53. 5 indexed citations
16.
Shibata, M, et al.. (1994). Peripheral nerve repair. Current Opinion in Orthopedics. 5(4). 102–107. 1 indexed citations
17.
Shibata, M, et al.. (1991). Microsurgical Toenail Transfer to the Hand. Plastic & Reconstructive Surgery. 88(1). 102–109. 25 indexed citations
18.
Kamiya, A., et al.. (1987). Optimum capillary number for oxygen delivery to tissue in man. Bulletin of Mathematical Biology. 49(3). 351–361. 8 indexed citations
19.
Takahashi, Takanori, Kosuke Kuwabara, & M Shibata. (1981). Sodium ion conductivities of phosphate derivatives. Solid State Ionics. 3-4. 237–242. 1 indexed citations
20.
Takahashi, Takehiko, Kosuke Kuwabara, & M Shibata. (1980). Solid-state ionics - conductivities of Na+ ion conductors based on NASICON. Solid State Ionics. 1(3-4). 163–175. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026